This opportunity is no longer accepting applications.
grant RFA-DA-25-021

Effect of HIV and Substance Use Comorbidity on the Placenta and Maternal Outcomes (R01 Clinical Trial Optional)

This grant opportunity focuses on researching the effects of HIV and antiretroviral therapy (ART) on the placenta during pregnancy. Although ART helps prevent the transmission of HIV from mother to child, it is linked to negative outcomes like preterm birth and stillbirth. Understanding the impact of HIV and ART on the placenta is crucial, especially in pregnant individuals who also experience…

Human immunodeficiency virus (HIV) infection is widely prevalent in individuals in the reproductive age group. Globally, an estimated 1.3 million people living with HIV (PWH) become pregnant each year (UNAIDS data, 2019). With the advent of antiretroviral therapy (ART), significant progress has …

Funding Source

Agency: National Institutes of Health
Sub-agency: National Institute on Drug Abuse
Program: SBIR

Dates

Opportunity Released: October 30, 2023
Open for Submission: October 30, 2023
Submission Deadline: November 15, 2024
Application Window Closes: November 15, 2024

Supporting links

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.